Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Feb. 15, 2017, 7:21 a.m. EST

Integra to buy J&J's Codman Neurosurgery business for $1.05 billion

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Integra LifeSciences Holdings Corp. (IART)
  • X
    Johnson & Johnson (JNJ)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Integra LifeSciences Holdings Corp. /zigman2/quotes/200866868/composite IART -3.24% said Wednesday that it was paying $1.05 billion in cash to buy Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ -1.05% Codman Neurosurgery business. Codman's devices are focused on hydrocephalus, neurocritical care and operative neurosurgery. Integra expects the deal to add 22 cents to adjusted earnings per share in the first year after closing. Integra said it will finance the purchase with cash on hand, use of its revolving credit facility and new senior secured term loan facility. Shares of Integra and J&J were still inactive in premarket trade. Over teh past three months, Integra's stock has climbed 8.2%, while J&J's has been little changed and the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.08% has gained 7.2%.

/zigman2/quotes/200866868/composite
US : U.S.: Nasdaq
$ 71.29
-2.39 -3.24%
Volume: 228,051
May 11, 2021 3:45p
P/E Ratio
35.77
Dividend Yield
N/A
Market Cap
$6.23 billion
Rev. per Employee
$370,775
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 168.48
-1.80 -1.05%
Volume: 6.72M
May 11, 2021 3:45p
P/E Ratio
29.80
Dividend Yield
2.51%
Market Cap
$448.39 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,143.25
-45.18 -1.08%
Volume: 1.99B
May 11, 2021 3:45p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.